Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-24-006261

Options or other derivatives

  • Chief Scientific Officer acquired 161,875 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Russell Alan J · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-08-12 Grant or award : show line 1 in the form Stock Option (Right to Buy) +138,750 138,750 D
2024-08-12 Grant or award : show line 2 in the form Restricted Stock Units +23,125 23,125 D
Loading xslF345X05/primarydocument.xml…